Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

Abroad (travel likely)RecruitingPHASE1

Conditions

Systemic Lupus Erythematosus (SLE) · Systemic Sclerosis · Sjogren's Syndrome (SS) · Inflammatory Myopathy · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis · Antiphospholipid Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Contact: Study coordinator (Dongmei Zhou) · zdm@xzhmu.edu.cn · 15252002644

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Systemic Lupus Erythematosus · Lupus Nephritis (LN) · Sjogren's Syndrome

Abroad (travel likely)RecruitingPHASE1

Bengbu, China

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Systemic Lupus Erythematosus (SLE) · Lupus Nephritis (LN) · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Hefei, China

A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases

Systemic Lupus Erythematosus (SLE) · Sjogren's Syndrome (SS) · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases

Systemic Lupus Erythematosus · Systemic Sclerosis (SSc) · Inflammatory Myopathy

Abroad (travel likely)RecruitingPHASE1

Tianjin, China